Moving mountains together
Collaborative Initiatives
Together we can move mountains. In collaborative initiatives, various investors enter into a dialogue with a company. Each initiative focuses on a specific topic, for example climate, biodiversity, nutrition or human rights. With the “Access to Nutrition Initiative,” Globalance has assumed co-leadership of the dialogue with Unilever since 2025.
“Access to Nutrition Initiative” for Healthy Diets
Healthy diets play a central social and economic role. They have the potential to reduce healthcare costs, contribute to a healthy and productive society, and lower the risk of chronic diseases. In an ageing society, healthy nutrition also supports longer, more independent lives with a higher quality of life. This is where the Access to Nutrition Initiative (ATNI) comes into play.
The core mission of this investor collaboration is to make healthy nutrition more accessible worldwide. To date, the initiative has published five global reports assessing 30 food companies with regard to their nutrition-related practices, such as product composition and marketing. Since 2025, we have been co-leading the engagement with Unilever.
Further investor initiatives
Climate Action 100+
«Climate Action 100+» is an investor-led initiative that works with the world’s largest greenhouse gas emitters to transition to net zero. In 2023, Globalance joined two teams of the initiative. Since 2025, we are involved as co-lead in the dialogue with Unilever.
Carbon Disclosure Project
We have been involved in the «Carbon Disclosure Project» (CDP), the leading platform for corporate environmental data, since 2020. In 2025, we were one of the signatory investors for the CDP request to twenty companies, calling for the disclosure of climate, forest, and water-related data.
Nature Action 100
Around half of global economic output depends on ecosystem services. Nature Action 100 targets the 100 companies with the greatest impact on nature, with the aim of preserving biodiversity and preventing the erosion of their own business foundations. In 2025, we continued our co-leadership together with Roche, and we remain actively engaged in 2026.
